Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

Although the novel cytidin analogue gemcitabine has shown superior anti-tumour activity than 5-fluorouracil in advanced pancreatic cancer, further improvements of therapeutic results are warranted. This goal might be achieved by combining gemcitabine with other active drugs. This trial evaluated the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Scheithauer, W, Kornek, G V, Raderer, M, Hejna, M, Valencak, J, Miholic, J, Kovats, E, Lang, F, Funovics, J, Bareck, E, Depisch, D
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 1999
Onderwerpen:
Regular Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363123/
https://ncbi.nlm.nih.gov/pubmed/10468299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690600
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items